Renal Anemia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. All patients participating in the ''Ruixiang Xinsheng'' patient assistance program in the database of China Primary Health Care Foundation. 2. Patients diagnosed with CKD anemia and undergoing dialysis (including peritoneal dialysis and hemodialysis); 3. Hemoglobin <12g/dl; 4. There is no ESA concomitant medication, and patients who are receiving ESA treatment must have an appropriate withdrawal period (Such as ESA three times a week, 3000IU/time, stop for three days, such as ESA once a week, 10000IU/time, stop for 7 days).
Exclusion criteria
Exclusion criteria: 1. Those who participated in the ''Ruixiang Xinsheng'' patient assistance program in the database of China Primary Health Care Foundation without signing the informed consent; 2. Patients who have participated in the ''Ruixiang Xinsheng'' patient assistance program in the database of the China Primary Health Care Foundation without receiving the medicine; 3. Aged = 3 times the upper limit of the normal range (ULN) at the screening visit; 7. Total bilirubin >=2 times ULN at the screening visit; 8. Pregnant and lactating women; 9. Patients with poorly controlled hypertension identified by doctors; 10. A patient who is judged by a doctor to have a serious illness; 11. Patients with existing malignant tumors.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Adverse drug reactions during treatment; | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse effects among different subgroups;Serious adverse reactions;Adverse reactions in special populations;Adverse events of special concern;Hemoglobin level changes from baseline;Hemoglobin treatment compliance; | — |
Countries
China
Contacts
Peking University First Hospital